Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Montelukast/Loratadine in Mexican Allergic Rhinitis Patients
NCT01673620Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2012
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of montelukast, loratadine in allergic rhinitis (AR), sponsored by Organon & Co.. Started Jul 2012; status: completed.
02
Drugs
montelukastloratadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01673620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673620.